Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome.
Phase of Trial: Phase III
Latest Information Update: 01 Aug 2017
At a glance
- Drugs Liraglutide (Primary)
- Indications Prader-Willi syndrome
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 12 Nov 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 23 Aug 2015 New trial record